vs

Side-by-side financial comparison of FARMERS & MERCHANTS BANCORP INC (FMAO) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($37.2M vs $32.5M, roughly 1.1× FARMERS & MERCHANTS BANCORP INC). On growth, FARMERS & MERCHANTS BANCORP INC posted the faster year-over-year revenue change (21.0% vs -57.1%). Over the past eight quarters, FARMERS & MERCHANTS BANCORP INC's revenue compounded faster (16.1% CAGR vs -46.5%).

Rainier Bancorporation was the Seattle-based parent corporation of Rainier National Bank, a Washington state bank with branches throughout the state. Rainier traced its roots back to the National Bank of Commerce, which was founded by Richard Holyoke in 1889. The name Rainier National Bank was adopted in 1974. Rainier Bancorp expanded into Alaska with the purchase of Anchorage's People's Bank & Trust in 1983 and into Oregon with the purchase of Gresham's Mount Hood Security Bank in 1986, expa...

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

FMAO vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.1× larger
ORGO
$37.2M
$32.5M
FMAO
Growing faster (revenue YoY)
FMAO
FMAO
+78.0% gap
FMAO
21.0%
-57.1%
ORGO
Faster 2-yr revenue CAGR
FMAO
FMAO
Annualised
FMAO
16.1%
-46.5%
ORGO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
FMAO
FMAO
ORGO
ORGO
Revenue
$32.5M
$37.2M
Net Profit
$9.8M
Gross Margin
30.8%
Operating Margin
39.5%
-185.1%
Net Margin
30.2%
Revenue YoY
21.0%
-57.1%
Net Profit YoY
16.8%
EPS (diluted)
$0.72

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FMAO
FMAO
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$32.5M
$225.6M
Q3 25
$31.3M
$150.9M
Q2 25
$29.6M
$101.0M
Q1 25
$28.1M
$86.7M
Q4 24
$26.8M
$126.7M
Q3 24
$25.5M
$115.2M
Q2 24
$25.1M
$130.2M
Net Profit
FMAO
FMAO
ORGO
ORGO
Q1 26
Q4 25
$9.8M
$43.7M
Q3 25
$8.9M
$21.6M
Q2 25
$7.7M
$-9.4M
Q1 25
$7.0M
$-18.8M
Q4 24
$8.4M
$7.7M
Q3 24
$6.5M
$12.3M
Q2 24
$5.7M
$-17.0M
Gross Margin
FMAO
FMAO
ORGO
ORGO
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
FMAO
FMAO
ORGO
ORGO
Q1 26
-185.1%
Q4 25
39.5%
28.1%
Q3 25
35.9%
13.7%
Q2 25
32.7%
-12.5%
Q1 25
31.2%
-30.9%
Q4 24
39.2%
8.1%
Q3 24
31.7%
5.4%
Q2 24
28.5%
-10.7%
Net Margin
FMAO
FMAO
ORGO
ORGO
Q1 26
Q4 25
30.2%
19.4%
Q3 25
28.3%
14.3%
Q2 25
26.0%
-9.3%
Q1 25
24.8%
-21.7%
Q4 24
31.2%
6.1%
Q3 24
25.5%
10.7%
Q2 24
22.6%
-13.1%
EPS (diluted)
FMAO
FMAO
ORGO
ORGO
Q1 26
Q4 25
$0.72
$0.31
Q3 25
$0.64
$0.11
Q2 25
$0.56
$-0.10
Q1 25
$0.51
$-0.17
Q4 24
$0.61
$0.05
Q3 24
$0.48
$0.09
Q2 24
$0.42
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FMAO
FMAO
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$91.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$370.9M
Total Assets
$3.4B
$520.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FMAO
FMAO
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$93.7M
Q3 25
$63.7M
Q2 25
$73.1M
Q1 25
$110.0M
Q4 24
$135.6M
Q3 24
$94.3M
Q2 24
$89.9M
Total Debt
FMAO
FMAO
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
FMAO
FMAO
ORGO
ORGO
Q1 26
Q4 25
$370.9M
$300.1M
Q3 25
$361.8M
$255.1M
Q2 25
$350.8M
$233.2M
Q1 25
$344.6M
$242.9M
Q4 24
$335.2M
$262.9M
Q3 24
$335.4M
$278.5M
Q2 24
$322.7M
$263.5M
Total Assets
FMAO
FMAO
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$3.4B
$598.7M
Q3 25
$3.4B
$509.8M
Q2 25
$3.3B
$461.1M
Q1 25
$3.4B
$467.4M
Q4 24
$3.4B
$497.9M
Q3 24
$3.4B
$446.3M
Q2 24
$3.3B
$443.2M
Debt / Equity
FMAO
FMAO
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FMAO
FMAO
ORGO
ORGO
Operating Cash FlowLast quarter
$36.7M
Free Cash FlowOCF − Capex
$35.0M
FCF MarginFCF / Revenue
107.8%
Capex IntensityCapex / Revenue
5.4%
Cash ConversionOCF / Net Profit
3.75×
TTM Free Cash FlowTrailing 4 quarters
$56.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FMAO
FMAO
ORGO
ORGO
Q1 26
Q4 25
$36.7M
$39.4M
Q3 25
$11.2M
$3.1M
Q2 25
$1.1M
$-32.9M
Q1 25
$11.0M
$-19.9M
Q4 24
$32.5M
$10.9M
Q3 24
$18.7M
$8.7M
Q2 24
$9.7M
$4.7M
Free Cash Flow
FMAO
FMAO
ORGO
ORGO
Q1 26
Q4 25
$35.0M
$34.8M
Q3 25
$10.7M
$844.0K
Q2 25
$385.0K
$-36.5M
Q1 25
$10.6M
$-23.6M
Q4 24
$30.6M
$7.6M
Q3 24
$18.3M
$6.1M
Q2 24
$9.2M
$2.9M
FCF Margin
FMAO
FMAO
ORGO
ORGO
Q1 26
Q4 25
107.8%
15.4%
Q3 25
34.3%
0.6%
Q2 25
1.3%
-36.1%
Q1 25
37.8%
-27.2%
Q4 24
114.1%
6.0%
Q3 24
71.7%
5.3%
Q2 24
36.5%
2.2%
Capex Intensity
FMAO
FMAO
ORGO
ORGO
Q1 26
Q4 25
5.4%
2.1%
Q3 25
1.5%
1.5%
Q2 25
2.4%
3.6%
Q1 25
1.4%
4.2%
Q4 24
7.0%
2.7%
Q3 24
1.4%
2.2%
Q2 24
2.3%
1.4%
Cash Conversion
FMAO
FMAO
ORGO
ORGO
Q1 26
Q4 25
3.75×
0.90×
Q3 25
1.26×
0.14×
Q2 25
0.14×
Q1 25
1.58×
Q4 24
3.87×
1.43×
Q3 24
2.86×
0.71×
Q2 24
1.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons